Nuchido Overview

  • Founded
  • 2017
  • Status
  • Private
  • Employees
  • 6
  • Latest Deal Type
  • 2ndary - Private

Nuchido General Information


Producer of scientific anti-ageing supplement intended to boost cellular nicotinamide adenine dinucleotide. The company's supplement boosts nicotinamide adenine dinucleotide levels that are essential to activate the Innate Immune System which is the body's first line of defence against viral infection, enabling customers to translate scientific advances in ageing research into products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • 1209 Orange Street
  • Wilmington
  • New Castle, DE 19801
  • United States
+1 (314) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nuchido Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 00000 Completed Generating Revenue
1. Seed Round 01-Apr-2017 00000 00000 Completed Generating Revenue
To view Nuchido’s complete valuation and funding history, request access »

Nuchido Executive Team (2)

Name Title Board Seat Contact Info
Nichola Conlon Ph.D Co-Founder & Chief Executive Officer
Sally Roberts Chief Financial Officer
To view Nuchido’s complete executive team members history, request access »

Nuchido Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial